Single and Multiple Dose Safety, Tolerability and Pharmacokinetics of the Selective M1 Receptor Partial Agonist HTL0018318 in Healthy Volunteers

被引：0

作者：

Nathan, Pradeep ^{[1
]}

Liptrot, Jan ^{[1
]}

Bakker, Charlotte ^{[1
]}

'tHart, Ellen ^{[1
]}

Klaassen, Erica ^{[1
]}

Prins, Samantha ^{[1
]}

van der Doef, Thalia ^{[1
]}

Walker, Mike ^{[1
]}

Brown, Giles ^{[1
]}

Brown, Alastair ^{[1
]}

Congreve, Miles ^{[1
]}

Weir, Malcolm ^{[1
]}

Marshall, Fiona ^{[1
]}

Cross, David ^{[1
]}

Groeneveld, Geert Jan ^{[1
]}

Tasker, Tim ^{[1
]}

机构：

[1] Sosei Heptares, Cambridge, England

来源：

NEUROPSYCHOPHARMACOLOGY | 2018年 / 43卷

关键词：

M1 and M4 Muscarinic Receptors; Phase; 1; Safety; Pharmacokinetics; Dementia;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

W51

引用

页码：S408 / S409

页数：2

共 50 条

[1] Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M1 receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study
Bakker, Charlotte
Tasker, Tim
Liptrot, Jan
Hart, Ellen P.
Klaassen, Erica S.
Doll, Robert Jan
Brown, Giles A.
Brown, Alastair
Congreve, Miles
Weir, Malcolm
Marshall, Fiona H.
Cross, David M.
Groeneveld, Geert Jan
Nathan, Pradeep J.
ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
[2] Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M1 receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study
Charlotte Bakker
Tim Tasker
Jan Liptrot
Ellen P. Hart
Erica S. Klaassen
Robert Jan Doll
Giles A. Brown
Alastair Brown
Miles Congreve
Malcolm Weir
Fiona H. Marshall
David M. Cross
Geert Jan Groeneveld
Pradeep J. Nathan
Alzheimer's Research & Therapy, 13
[3] Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects
Bakker, Charlotte
van der Aart, Jasper
Labots, Geert
Liptrot, Jan
Cross, David M.
Klaassen, Erica S.
Dickinson, Steve
Tasker, Tim
Groeneveld, Geert Jan
DRUGS IN R&D, 2021, 21 (03) : 295 - 304
[4] Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects
Charlotte Bakker
Jasper van der Aart
Geert Labots
Jan Liptrot
David M. Cross
Erica S. Klaassen
Steve Dickinson
Tim Tasker
Geert Jan Groeneveld
Drugs in R&D, 2021, 21 : 295 - 304
[5] First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1-receptor partial agonist for the treatment of dementias
Bakker, Charlotte
Tasker, Tim
Liptrot, Jan
Hart, Ellen P.
Klaassen, Erica S.
Prins, Samantha
Doef, Thalia F.
Brown, Giles A.
Brown, Alastair
Congreve, Miles
Weir, Malcolm
Marshall, Fiona H.
Cross, David M.
Groeneveld, Geert Jan
Nathan, Pradeep J.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (07) : 2945 - 2955
[6] Single- and Multiple-Dose Pharmacokinetics, Safety, and Tolerability of the Selective α7 Neuronal Nicotinic Receptor Agonist, ABT-107, in Healthy Human Volunteers
Othman, Ahmed A.
Lenz, Robert A.
Zhang, Jun
Li, Jianling
Awni, Walid M.
Dutta, Sandeep
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (04): : 512 - 526
[7] SINGLE -DOSE PHARMACOKINETICS AND TOLERABILITY OF ABT-089, A NOVEL NEURONAL NICOTINIC RECEPTOR PARTIAL AGONIST, IN HEALTHY VOLUNTEERS
Xiong, Hao
Garimella, Tushar
Locke, Charles
Awni, Walid
Dutta, Sandeep
JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1068 - 1068
[8] A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer's disease
Nathan, Pradeep. J. J.
Millais, S. Babli
Godwood, Alex
Dewit, Odile
Cross, David. M. M.
Liptrot, Janet
Ruparelia, Bharat
Jones, Stephen Paul
Bakker, Geor
Maruff, Paul. T. T.
Light, Gregory. A. A.
Brown, Alastair J. H.
Weir, Malcolm Peter
Congreve, Miles
Tasker, Tim
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
[9] Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers
Grundy, John S.
King, Christopher D.
Adams, John W.
Cabell, Christopher H.
PULMONARY CIRCULATION, 2020, 10 (02)
[10] Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses
Rolan, Paul
Gibbons, Jacqueline A.
He, Lin
Chang, Eppie
Jones, Drew
Gross, Matthew I.
Davidson, Jennifer Bahr
Sanftner, Laura M.
Johnson, Kirk W.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (06) : 792 - 801

← 1 2 3 4 5 →